Project Grant W81XWH2110035

The federal Project Grant award R43HL176331, funded by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), aims to develop and test a bidirectional synchronous flow-controlled ventilation system to improve oxygenation and ventilation in acute respiratory distress syndrome (ARDS). The $1,160,157 award will enable Liberandum Technologies, Inc. to conduct computational fluid dynamics analysis, develop a prototype device, and...

Sperry Medtech Inc. received a $255,382 Project Grant award from the National Science Foundation Division of Industrial Innovation on March 1, 2021 to develop a novel respiratory ventilator for clinical care in response to COVID-19. The award was made under the NSF's Engineering program (CFDA 47.041), which seeks to improve quality of life and economic strength through engineering research and innovation. With this funding, Sperry Medtech will work to advance a new ventilator design that...

This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $1,052,276 to Lasarrus Clinic And Research Center Inc. to develop a wearable multimodal sensor system for remote monitoring of patients with chronic obstructive pulmonary disease (COPD). The project aims to enhance adherence to remote monitoring and early symptom recognition, in order to reduce COPD readmissions and healthcare costs....

This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health, under the Cardiovascular Diseases Research program (CFDA 93.837), provides $842,408 to support the development and evaluation of the Aerosolve Biohelmet. The Aerosolve Biohelmet is a personal negative pressure device designed to rapidly isolate and safely transport patients with highly transmissible respiratory illnesses like COVID-19, influenza, and tuberculosis. The...

The National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research Federal Grant Program (CFDA 93.837), awarded a $295,924 Project Grant to Convergent Engineering, Inc. to develop a prototype decision support system for personalizing mechanical ventilation care. The proposed system aims to simplify the use of esophageal pressure measurements and provide clinicians with enhanced data and decision support to optimize ventilator settings and prevent complications...

The National Heart, Lung, and Blood Institute (NHLBI) awarded a $333,810 Project Grant (CFDA 93.837 - Cardiovascular Diseases Research) to Novis Products, LLC to develop the RMT Complete, an all-in-one respiratory muscle training device and mobile application. The RMT Complete aims to enhance breathing function and quality of life for patients with chronic obstructive pulmonary disease (COPD) by combining features such as an integrated manometer, wide resistance training range, real-time...

This Project Grant from the National Science Foundation's Division of Industrial Innovation, under the Engineering program (CFDA 47.041), provides $256,000 to Colabs, Inc. to develop an automated airway and ventilator system that eliminates human operator variability during cardiopulmonary resuscitation (CPR). The system aims to reliably place an airway tube for ventilation, synchronize air delivery with chest compressions, and enable cardiac defibrillation at lower voltages through an electrode...

The National Heart, Lung, and Blood Institute (NHLBI) awarded a $397,891 Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) to Advanced Medical Electronics Corp (A M E C), a for-profit medical technology company. The grant funding supports the development of an innovative, single-operator pneumothorax decompression device to improve the safety and time efficiency of therapeutic decompression procedures for neonatal patients. The project aims to create a prototype...

The National Heart, Lung, and Blood Institute (NHLBI) awarded a $269,922 Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) to Steth X Microsystems Inc., a for-profit company in Atlanta, Georgia. The grant project aims to develop a smart, wearable contact microphone patch for extended and remote monitoring of lung functions, particularly for respiratory diseases like asthma and chronic obstructive pulmonary disease (COPD). The wearable patch will utilize a novel,...

This $8.7 million project grant from the Department of the Army Medical Command, under the Military Medical Research and Development program (CFDA 12.420), supports the development of patient care technologies for permanent ambulatory artificial lung support from May 2022 to April 2026. Carnegie Mellon University is the primary awardee and will develop technologies to transition a pulmonary assist system to long-term support of chronic lung disease patients. Vanderbilt University Medical...